Arcturus Therapeutics Holdings Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $82.0 | $152.3 | $166.8 | $206.0 | $12.4 |
| Operating income | -$76.3 | -$95.7 | -$78.2 | $12.2 | -$202.9 |
| Net income | -$65.8 | -$80.9 | -$29.7 | $9.3 | -$203.7 |
| Cash Flow Statement | |||||
| Free cash flow | -$74.5 | -$60.4 | -$21.0 | $24.3 | -$138.4 |
Shares outstanding 28.4M · Free float 94.3%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.